Viewing Study NCT02029157


Ignite Creation Date: 2025-12-24 @ 6:40 PM
Ignite Modification Date: 2025-12-29 @ 10:40 PM
Study NCT ID: NCT02029157
Status: COMPLETED
Last Update Posted: 2017-10-09
First Post: 2013-12-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC)
Sponsor: Kyowa Kirin Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module